Healthcare >> CEO Interviews >> April 26, 1999

R. Ian Lennox – Drug Royalty Corporation (

R. IAN LENNOX is President and Chief Executive Officer of Drug Royalty Corporation Inc. based in Toronto, Canada. Mr. Lennox was President and CEO of Monsanto Canada Inc., between 1991-1996 where he managed a diverse portfolio of businesses including pharmaceuticals, agricultural and performance chemicals, food ingredients as well as an emerging biotechnology presence. Under his leadership, Monsanto acquired several new businesses, built a high growth Roundup franchise and increased operating earnings fourfold. Prior to his return to Canada, he spent ten years with Monsanto Company as Director, Latin American Operations, Director, Western United States Region, and Business Manager, Pharmaceuticals. In addition to his responsibilities at Drug Royalty, Mr. Lennox is a member of the board of several publicly traded firms including GenSci Inc., Hemosol Inc. and Marsulex Inc., and MDS Capital Corp. Mr. Lennox has played an important role in industry-government community associations in Canada. He was Chairman, International Centre of Agriculture, Science and Technology based in Saskatoon (1992-94); Chairman of the Canadian Chemical Advisory Council based in Ottawa (1994-96); Chairman of the Canadian Chemical Producers' Association (1995-96); Chairman of the 1966 Peel United Way Campaign; Chairman of The Mississauga Hospital Foundation (1994-96) and a member of the board of the Mississauga Hospital and Junior Achievement of Canada (1991-95). Mr. Lennox was a recipient of the Mississauga Citizenship Award (1996) and the Rotary Club's Paul Harris Fellowship Award (1977). Mr. Lennox is an honours graduate in physiology and pharmacology. He has an MBA from the Ivey School of Business, University of Western Ontario, and studied advanced business management at Columbia Business School in New York. He resides in Oakville, Ontario with his wife, Barbara, and their four sons, Ryan, Craig, Derek and Blake. Profile
TWST: Give us a brief overview of Drug Royalty, Corporation your

history, your products, your activities, your customers, those kinds of


Mr. Lennox: Drug Royalty is building an